Advertisement
Home 2015

Archives

Praluent (alirocumab) injection has been approved by the U.S. Food and Drug Administration for use in addition to diet and maximally tolerated statin therapy in adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease

FDA Approves Praluent for Certain Cases of High Cholesterol

0
First in a new class of injectable cholesterol-lowering medications
A new diagnostic to differentiate between HIV-1 antibodies

FDA Approves Test to Differentiate HIV Viruses

0
Among people two years and older
Technivie (ombitasvir

FDA Approves Technivie for Hepatitis C

0
For people with chronic hepatitis C genotype 4
Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat locally advanced basal cell carcinoma that has returned despite surgery or radiation. The treatment is sanctioned for people who are not candidates for additional surgery or radiation.

FDA Approves Odomzo for Recurring Basal Cell Carcinoma

0
Medication is designed to inhibit the Hedgehog pathway
Stillbirths have eclipsed infant deaths for the first time in the United States

CDC: Stillbirths Now Outnumber Infant Deaths in U.S.

0
Experts point to dropping infant death rates, racial disparities in care, and fertility treatments as factors
Fewer than half of U.S. teenagers aged 15 to 19 are having sex

CDC: U.S. Teens Waiting Longer to Have Sex

0
Report finds fewer than half of those aged 15 to 19 have had intercourse

CMS Finalizes Decision to Cover HPV Testing for Cervical Cancer

0
AAFP encouraged CMS to consider coverage and follow through on proposal
A proposed rule from the Centers for Medicare & Medicaid Services would implement physicians' calls to pay for end-of-life counseling

CMS May Adopt Doctors’ Calls for End-of-Life Counseling

0
Two new codes would be established; would be used for conversations about care options
Measures can be taken to encourage patients to use patient portals to help ensure practices meet current Stage 2 meaningful use requirements

AMA Suggests Ways to Encourage Use of Patient Portals

0
Suggestions include training staff on portal use; showing patients how to use the portal
Experts are speaking out against "sunburn art

Trend Alert: Sunburn ‘Art’ Growing Presence on Social Media

0
Experts warn against the dangers of the increasingly popular practice